Hims & Hers 3Q 2026: Revenue $890.37M, EPS ($0.14) — 10-Q Summary

What happened

Hims & Hers reported third-quarter 2026 revenue of $890.37M, up 49% year over year. It swung from net income to a net loss, as stronger U.S. sales and acquisition-led international growth were outweighed by higher product, shipping, fulfillment, operating, and legal costs.

Confirmed

Global impact / market context

Revenue growth shows that customer demand and expansion are increasing sales, but the move to a net loss shows costs are growing faster than the business can absorb. Higher product, shipping, fulfillment, operating and legal costs could limit cash available to fund further growth.

Analyst inference

U.S. revenue rose 21%, while revenue outside the U.S. increased 321%, primarily reflecting acquisitions and geographic expansion. Subscribers grew 13% to about 2.8 million, but gross margin, meaning the share of sales remaining after direct costs, fell to 57% from 74%.

Confirmed

What to watch

1. Watch whether sales growth continues to translate into improved earnings: the company reported higher revenue but a net loss, with product, shipping and fulfillment costs weighing on results. Analyst inference
2. Track gross margin, meaning the share of sales left after direct costs, and whether it stabilizes as weight-loss offerings, international growth and shipping cadence affect costs. Analyst inference
3. The article says weight-loss offerings and a shift toward branded GLP-1 medications; the supplied text ends before describing the full strategy or its scale. Confirmed

Evidence

• Original source link unavailable